TELA Bio to Participate in Upcoming Needham & Co. 21st Annual Healthcare Virtual Conference
MALVERN, Pa., March 30, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that the Company will participate in the Needham & Co. 21st Annual Healthcare Virtual Conference on April 12th, 2022.
TELA Bio’s management is scheduled to present at the Needham & Co. 21st Annual Healthcare Virtual Conference on April 12th, 2022, at 2:15pm ET. Interested parties can access the live and archived webcast at ir.telabio.com.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Investor Contact
Greg Chodaczek
332-895-3230
[email protected]
Disclaimer: This content is distributed by The GlobeNewswire 
